title: Improved efficiency of canine nucleus transfer using roscovitine-treated canine fibroblasts.
abstract: The aim of this study was to investigate whether roscovitine (the cyclin-dependent kinase 2 inhibitor) effectively induces synchronization of the donor cell cycle at G0/G1 and to examine the effect of donor cell cycle synchronization protocols on canine somatic cell nucleus transfer. Canine fibroblasts were obtained from skin biopsy cultures taken from a 7-yr-old retriever. The donor cell cycle was synchronized either by culturing cells to reach confluency or by treating cells with 15 microg/mL roscovitine for 24h. Cell cycle stages and apoptosis were analyzed by flow cytometry. After synchronization of the donor cell cycle, cells were placed with enucleated in vivo-matured dog oocytes, fused by electric stimulation, activated, and transferred into 18 naturally estrus-synchronized surrogates. There was no significant difference in cell cycle synchronization and apoptosis rates between the confluent and roscovitine groups. After transfer of reconstructed embryos, pregnancy was detected in three of nine surrogates that received cloned embryos reconstructed with roscovitine-treated cells, whereas only one of nine surrogates was pregnant after transfer of cloned embryos reconstructed with confluent cells. One pregnant female from the confluent cell group delivered one live and one dead pup, but the live one died within 5 days after birth. Three pregnant females from the roscovitine-treated cell group delivered eight live pups and one dead pup, and one of eight live pups died within 6 days after birth. In conclusion, the current results demonstrated that reconstructing embryos with roscovitine-treated cells resulted in increased efficiency of canine somatic cell nucleus transfer.
authors.affiliation: Department of Theriogenology and Biotechnology, College of Veterinary Medicine, Seoul National University, Seoul, 151-742, Republic of Korea.
authors.forename: H J
authors.initials: HJ
authors.lastname: Oh
authors.forename: S G
authors.initials: SG
authors.lastname: Hong
authors.forename: J E
authors.initials: JE
authors.lastname: Park
authors.forename: J T
authors.initials: JT
authors.lastname: Kang
authors.forename: M J
authors.initials: MJ
authors.lastname: Kim
authors.forename: M K
authors.initials: MK
authors.lastname: Kim
authors.forename: S K
authors.initials: SK
authors.lastname: Kang
authors.forename: D Y
authors.initials: DY
authors.lastname: Kim
authors.forename: G
authors.initials: G
authors.lastname: Jang
authors.forename: B C
authors.initials: BC
authors.lastname: Lee
mesh_terms: D000818:Animals; D017209:Apoptosis; D001724:Birth Weight; D002453:Cell Cycle; D002470:Cell Survival; D019976:Cloning, Organism / Q000379:methods*; D004285:Dogs; D005260:Female; D005347:Fibroblasts / Q000187:drug effects*; D005434:Flow Cytometry; D008297:Male; D053652:Nuclear Transfer Techniques; D009865:Oocytes / Q000166:cytology / Q000502:physiology / Q000648:ultrastructure; D010920:Placenta / Q000033:anatomy & histology; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000662:veterinary; D018873:Pregnancy Rate; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*; D011687:Purines / Q000494:pharmacology*; D000077546:Roscovitine
chemical_list: D047428:Protein Kinase Inhibitors; D011687:Purines; D000077546:Roscovitine